Recommended Pages at gene.com
Infinite Variations
gene.com — “Infinite Variations” View full resource at gene.com
Most Recently Shared on March 2, 2012 at 11:05 pm By:
Listen to what the genes of the 1,200 smartest people in the world sound like! http://t.co/2EIwr0Mq Fantastic! @genentechnews #TED #hscmeu
Genentech: Careers: Social Media Hub
gene.com — “Genentech: Careers: Social Media Hub” View full resource at gene.com
Most Recently Shared on February 10, 2012 at 5:05 pm By:
Thanks! | RT @markmapstone: Biotechnology company Genentech makes great use of social media http://t.co/1jMw8icI
Genentech: Newsroom: Press Releases: News Release February 7, 2012
gene.com — “Genentech News Release - FDA Grants Genentech's Pertuzumab Priority Review for Previously Untreated HER2-Positive Metastatic Breast Cancer” View full resource at gene.com
Most Recently Shared on February 7, 2012 at 5:01 pm By:
#Genentech announced the #FDA has granted priority review for pertuzumab http://t.co/kgyAKwSF
Genentech: Research & Early Development: Innovation In Research
gene.com — “Genentech: Research & Early Development: Innovation In Research” View full resource at gene.com
Most Recently Shared on February 2, 2012 at 11:12 pm By:
Frederic de Sauvage explains #Genentech's role in understanding the relationship btwn the Hedgehog pathway & cancer http://t.co/tkhwruUu
Genentech: Newsroom: Press Releases: News Release January 30, 2012
gene.com — “Genentech News Release - FDA Approves Erivedge (Vismodegib) Capsule, the First Medicine for Adults with Advanced Basal Cell Carcinoma” View full resource at gene.com
Most Recently Shared on January 30, 2012 at 4:13 pm By:
New #Genentech medicine is 1st #FDA - approved medicine for adults w/ advanced basal cell carcinoma http://t.co/p4EDeaNB
Genentech: Newsroom: Press Releases: News Release January 13, 2012
gene.com — “Genentech News Release - Genentech Announces First Milestone Payment to Device-Maker ForSight VISION4, Inc. in Development of Sustained Delivery Lucentis” View full resource at gene.com
Most Recently Shared on January 13, 2012 at 2:32 pm By:
Genentech announces milestone payment to ForSight VISION4, Inc. in dev of sustained delivery device; plans to file IND http://t.co/Bb8Tx5Yd
Genentech: Press Releases - News Release (Printer Friendly Version)November 8, 2011
gene.com — “Genentech News Release - FDA Accepts Genentech's New Drug Application For Vismodegib in Advanced Form of Skin Cancer” View full resource at gene.com
Most Recently Shared on January 8, 2012 at 6:21 pm By:
Eric D Whitman, MD Doctor, Surgeon, Oncologist, and Physician
With the excitement over new #melanoma drugs, don't overlook new drug on way for advanced basal cell cancer http://t.co/nVL22TLN
Genentech: Newsroom: Press Releases: News Release November 18, 2011
gene.com — “Genentech: Newsroom: Press Releases: News Release November 18, 2011” View full resource at gene.com
Most Recently Shared on November 18, 2011 at 4:54 pm By:
FDA revokes approval of Avastin's use for breast cancer in the US http://t.co/HC7e5I6j
Genentech: Newsroom: Press Releases: News Release November 8, 2011
gene.com — “Genentech: Newsroom: Press Releases: News Release November 8, 2011” View full resource at gene.com
Most Recently Shared on November 9, 2011 at 6:18 am By:
Genentech announced the FDA has granted priority review for vismodegib http://t.co/6AVDBPbM
Genentech: Newsroom: Press Releases: News Release November 5, 2011
gene.com — “Genentech: Newsroom: Press Releases: News Release November 5, 2011” View full resource at gene.com
Most Recently Shared on November 5, 2011 at 9:12 pm By:
Data presented at ACR showed Genentech medicine significantly improved signs and symptoms of rheumatoid arthritis. http://t.co/T9lWZobb
Genentech: Newsroom: Press Releases: News Release October 19, 2011
gene.com — “Genentech: Newsroom: Press Releases: News Release October 19, 2011” View full resource at gene.com
Most Recently Shared on October 20, 2011 at 5:02 am By:
Data at ECTRIMS showed Genentech medicine maintained reduction in disease activity for MS patients through 96 weeks. http://t.co/Zny5vapk
Genentech: Newsroom: Press Releases: News Release September 24, 2011
gene.com — “Genentech: Newsroom: Press Releases: News Release September 24, 2011” View full resource at gene.com
Most Recently Shared on September 24, 2011 at 10:04 pm By:
Genentech investigational medicine improved PFS & safety in HER2+ metastatic breast cancer; Abstract 5001 #EMCC2011 http://t.co/DC37sfeA
Genentech: Newsroom: Press Releases
gene.com — “Genentech: Newsroom: Press Releases” View full resource at gene.com
Most Recently Shared on September 12, 2011 at 11:20 am By:
Raymond DuBois Physician, Doctor, Internist, Gastroenterologist, and Health Executive
Genentech Submits New Drug Application to FDA for Vismodegib for Rare Form of Advanced Skin Cancer (Basal Cell Ca): http://t.co/DPiuQ4b
Genentech: Newsroom: Press Releases: News Release September 12, 2011
gene.com — “Genentech: Newsroom: Press Releases: News Release September 12, 2011” View full resource at gene.com
Most Recently Shared on September 12, 2011 at 11:01 am By:
GNE submits new drug application to FDA for advanced basal cell carcinoma, a rare skin cancer http://t.co/G0OwlRe
Genentech: Newsroom: FDA Approves New Personalized Medicine
gene.com — “Genentech: Newsroom: FDA Approves New Personalized Medicine” View full resource at gene.com
Most Recently Shared on August 17, 2011 at 5:19 pm By:
More information and materials for reporters available on Genentech’s Zelboraf http://t.co/KfYSIQP
